Allergy and Asthma Proceedings

Article	Citations
Impact of steroids on the immune profiles of children with asthma living in the inner-city	29
Pearls and pitfalls: Adverse cutaneous reactions after COVID-19 vaccination	28
The role of leukocyte activation in suspected Non-IgE excipient-related COVID-19 vaccine reactions: An exploratory hypothesis-driven study of pathogenesis	27
Future directions in allergen immunotherapy	25
Real-world reporting rates of administration-site reactions with on-demand treatment of hereditary angioedema attacks	22
Association of exposure to ambient particulate matter with asthma in children: Systematic review and meta-analysis	21
Hereditary Angioedema: Impact of COVID-19 pandemic stress upon disease related morbidity and well-being	20
Clinical remission in patients with severe eosinophilic asthma treated with mepolizumab: A post-hoc analysis of RELIght study	20
Venom allergen immunotherapy	20
Operationalizing shared decision making in clinical practice	20
Breathing through the night: A meta-analysis of childhood asthma and obstructive sleep apnea in sleep-disordered contexts	19
Molecular allergy diagnostics in predicting oral cow's milk challenge outcome in Finnish children	19
Demographics and characteristics of leadership at allergy and immunology fellowships in the U.S. as of 2022	17
For the Patient	17
For the Patient	17
Quality of life in primary immunodeficiency: Its contribution to shared decision-making and patient outcomes	16
Evaluation and management of chronic cough in adults	15
Body weight trajectory of non-obese asthmatics: Relationship with inhaled corticosteroids maintenance therapy	15
TEV/FEV3 as a coherent metric of small airway dysfunction in childhood asthma	14
Assessment of pediatric patients with suspected nonsteroidal anti-inflammatory drug hypersensitivity	14
Recurrent full-body rash following chemotherapy initiation in a multiple myeloma patient	14
Positive perception of COVID-19 vaccination in HAE: No significant impact of vaccination on disease course	13
The burden of systemic corticosteroids in patients with chronic rhinosinusitis with nasal polyps	13
Comparison of commercial allergen extract with various milk products of skin prick tests in diagnosing cow's milk protein allergy	13
Optimizing diagnostic approaches for allergic bronchopulmonary aspergillosis: Comparative analysis of IgG/IgE ELISA and serum precipitins assays	13

Diagnostic utility of basophil CD203c expression in β-lactam allergy	12
Systematic review of omalizumab for refractory clonal and non-clonal mast cell activation syndrome	12
Association between air pollution and the prevalence of allergic rhinitis in Chinese children: A systematic review and meta-analysis	12
Unraveling allergic, pseudoallergic, and idiosyncratic complexities of hypersensitivity reactions to NSAIDs	12
The safety of initial single therapeutic dose challenge with a 5-day prolonged drug provocation test in children with a history of low-risk non-immediate reactions to beta-lactam antibiotics	12
Epinephrine autoinjector prescribing following anaphylaxis presentation to the emergency department	12
Artificial intelligence and allergy: Shaping the future of diagnosis and therapy	12
For the Patient	12
Utility of basophil activation tests in the diagnosis of cross-intolerance to nonsteroidal anti-inflammatory drug reactions	12
Effects of mechanical washing and drying on the removal of pet allergens	11
For the patient	11
Navigating the management complexity in long-term asymptomatic immunodeficiency	11
Can depression and anxiety be predicted in hereditary angioedema? A comprehensive assessment	11
A tribute to allergy and immunology fellowship training program directors and to the fellows they train	11
Is it time for the A/I (allergist/immunologist) to embrace AI (artificial intelligence) in diagnosis and treatment of the inborn errors of immunity?	11
Abstracts Presented at the Western Society of Allergy, Asthma & Immunology, February 4‐8, 2024, Koloa, Hawaii	11
Eosinophilic granulomatosis with polyangiitis in allergic asthma: Efforts to make early diagnosis possible	10
Presented at the Western Society of Allergy, Asthma & Immunology, February 5‐9, 2023, Kamuela, Hawaii	10
Oral food challenge to milk is still necessary to diagnose cow's milk allergy and should be conducted in adequate facilities	10
Exhaled breath condensate thymic stromal lymphopoietin, OX40 ligand, eotaxin, and interleukin-23 in children with atopic dermatitis and persistent wheeze	10
Long-term efficacy of the sublingual and subcutaneous routes in allergen immunotherapy	10
A case of a rash after tetanus-diphtheria-pertussis and meningococcal vaccination	10
From burden to breakthrough: Advances in hereditary angioedema, drug allergy, and allergic disease prevention	10
Real-world effectiveness of dupilumab versus benralizumab and mepolizumab	10
Metal implant allergy: A retrospective cohort analysis at a university allergy practice	10
Shared decision-making in the management of hereditary angioedema: An analysis of patient and physician perspectives	9
Benralizumab in the management of rare primary eosinophilic lung diseases	9
Evaluation of atopic diseases in patients with allergic contact dermatitis	9
The long COVID syndrome: A conundrum for the allergist/immunologist	9
Markers of eosinophilic airway inflammation in patients with asthma and allergic rhinitis	8
Proton-pump inhibitors are associated with an increased risk of asthma: A nationwide nested case-control study	8
Overview of secondary immunodeficiency	8
Primary Immunodeficiency: Specific antibody deficiency with normal IgG	8
Impact of penicillin allergy labels among pneumonia admissions at an academic children's center	8
Efficacy of anti-interleukin 5 therapy in hypereosinophilic syndrome: An updated systematic review and meta-analysis	8
Early clinical improvement of anosmia and sinus nitric oxide in chronic rhinosinusitis with nasal polyps subjects treated with dupilumab	8
Follow-up after discontinuation of omalizumab in patients with moderate-to-severe asthma: A systematic review	8
Adding tiotropium or long-acting β2-agonists to inhaled corticosteroids: Asthma-related exacerbation risk and healthcare resource utilization	8
Abstracts published from the New England Society of Allergy Annual Fall Meeting, October 22‐23, 2022, Portsmouth, NH	8
Curcumin does not significantly affect immediate skin tests	8
Penicillin allergy labels are associated with a greater number of courses of antibiotics after hospitalization	8
Cost-effectiveness of school integrated pest management and air filtration in students with asthma	8
Hematopoietic stem cell transplantation for primary immunodeficiency	8
Rethinking the management of hereditary angioedema	8
For the Patient	8
Vaccinating patients on biologics for atopic disease: Clinical considerations and evidence-based recommendations	7
2-Octyl cyanoacrylate, a hidden allergen, a common cause of postsurgical allergic contact dermatitis	7
Immunodeficiency: Burden of Illness	7
Diagnosis of eosinophilic esophagitis in patients with dysphagia during the Coronavirus Disease 2019 (COVID-19) pandemic	7
Efficacy of parenteral bronchodilators on ventilatory outcomes in pediatric critical asthma: a national cohort study	7

A masquerade of recurrent anaphylaxis	7
Predictive factors of recurrence after omalizumab cessation in the elderly with urticaria: A real-life study	7
Assessing cross-reactivity in allergen immunotherapy	7
Real-world surveillance of standardized quality (SQ) house dust mite sublingual immunotherapy tablets for 3 years in Japan	7
Delayed pressure urticaria successfully treated with omalizumab: A tertiary-level health-care center experience	7
Multicenter questionnaire study investigating characteristics of adults with unexplained chronic cough versus explained chronic cough	7
Essentials of an immunodeficiency primer: A practical reference for the allergist/immunologist and the allergy-immunology fellow-in-training (FIT)	7
Peanut allergy in an adult following cardiac transplant from a non-atopic donor	7
Real-world effectiveness and predictors of super-responders to dupilumab in a Chinese uncontrolled asthma cohort	7
Quality of life and burden of disease in patients with hereditary angioedema and their caregivers	7
Initial updosing phase of oral immunotherapy improves quality of life and psychological burden in parents of children with food allergy	7
Clinical and economic burden of chronic rhinosinusitis with nasal polyposis: A U.S. administrative claims analysis	7
Winged hymenoptera: Discordance between In vitro and In vivo sensitization	7
Evaluation of allergic diseases in children diagnosed with cutaneous mastocytosis	7
The long-term outcomes of mepolizumab treatment at 100 mg dose on idiopathic chronic eosinophilic pneumonia: A real-life experience	7
Evaluation of disease control after SARS-CoV-2 infection or vaccination in patients with NSAID-exacerbated airway disease	6
Impact of perinatal risk factors on pediatric asthma: A systematic review and meta-analysis	6
Genetically-determined defects of T cell development	6
Efficacy and safety of Janus kinase selective inhibitors in the treatment of atopic dermatitis: A systematic review and meta-analysis	6
Comorbidity burden in patients with anaphylaxis: A 25-year nationwide population-based matched case‐control study	6
Early testing and grade of the reaction are affecting factors of skin test positivity in β-Lactam allergies	6
For the patient	6
Influence of aeroallergen sensitization and nasal polyposis on mepolizumab response in eosinophilic severe asthma	6
Long-term omalizumab treatment outcomes in patients with allergic bronchopulmonary aspergillosis	6
Interleukin-33, endothelin-1, and inflammatory parameters in chronic spontaneous urticaria	6
A confluence of advanced treatment options for atopic dermatitis, eosinophilic lung diseases and chronic urticaria brought about by the revolutionary discovery of biologics and Janus kinase inhibitors	6
Treatment options for moderate to severe atopic dermatitis	6
Blended problem based learning in postgraduate education: The Eastern Allergy Conference and the PBL Institute experience	6
Abstracts presented at the Eastern Allergy Conference, June 2‐5, 2022, Palm Beach, Florida	6
Predictors of relapse after omalizumab withdrawal in chronic spontaneous urticaria: Role of baseline autoimmunity and hematologic indices: CSU Relapse After Omalizumab Withdrawal	6
Real-world surveillance of standardized quality (SQ) house dust mite sublingual immunotherapy tablets for 3 years in Japan	6
Mechanisms and biomarkers of subcutaneous immunotherapy and sublingual immunotherapy in allergen immunotherapy	6
Anaphylaxis: Long-term management and resources	6
Expanding horizons of omalizumab: New frontiers in asthma and beyond	6
The COVID-19 impact on severe uncontrolled asthma costs and biologic use	5
Specific immunoglobulin E for aeroallergens: 0.35 kUA/L cutoff value is too low	5
Peptide immunotherapy for aeroallergens	5
Factors influencing the quality of life in children with atopic dermatitis in Korea: A multicenter cross-sectional study	5
Cat allergy in children and the effect of the COVID-19 pandemic	5
Comparison of clinical characteristics in primary immunodeficiency patients based on the presence of autoimmunity or autoinflammation	5
Studies of methylated CpG ODN from Bifidobacterium longum subsp. infantis in a murine model: Implications for treatment of human allergic disease	5
Successful rapid liposomal amphotericin B desensitization in pediatric case series	5
Clinical implications of asthma endotypes and phenotypes	5
A comparative study of chronic spontaneous urticaria and chronic mast cell mediated angioedema	5
A review of allergen immunotherapy in asthma	5
Salivary and serum IgA and IgG after COVID-19 and after immunization with COVID-19 vaccines	5
Treatment of eosinophilic esophagitis with immune modulating agents	5
The lymphocyte-eosinophil to neutrophil-monocyte ratio as a potential composite biomarker associated with asthma exacerbations in adults	5
Comprehensive assessment of allergic manifestations including drug hypersensitivity in adult patients with inborn errors of immunity	5
In-vivo allergen extract potency is maintained in a sublingual immunotherapy maintenance vial of pollens and mites	4
An infant with chronic relapsing urticaria	4
Clinical predictors of breakthrough reactions during initial rapid drug desensitizations to platinum chemotherapeutics	4
Across the arc of allergy: From maternal immune tolerance to food sensitization pathways and lifesaving anaphylaxis care	4
A systematic review and meta-analysis exploring the bidirectional association between asthma and gastroesophageal reflux disease in children	4
Management and referral patterns for new-onset chronic cough in primary care patients	4
Is atopic comorbidity increased in proctocolitis?	4
Comparative analysis of demographic and clinical features in common variable immunodeficiency and selective immunoglobulin G deficiency	4
Evaluation of direct oral provocation test results in mild cutaneous reactions to cephalosporins in children	4
For the patient	4
Unmasking multifactorial dermatitis: The case for comprehensive diagnostic guidelines in adult atopic dermatitis	4
The diagnostic accuracy of spirometry versus peak expiratory flow test for follow-up of adult asthma patients at primary care level	4
Removing penicillin allergy label in a hospitalized adolescent with a remote penicillin and recent cephalosporin allergy	4
Current concepts in optimized construction of allergen immunotherapy vaccines: Practical implications	4
The utility of shared decision making in the management of hereditary angioedema	4
Assessment of mask use on oxygen saturation in adults and children with asthma	4
Dose-dependent association between inhaled corticosteroid use and risk of obesity and metabolic syndrome in asthma	4
Aeroallergen immunotherapy update: Developments since the third Practice Parameter	4
Reply	4
Integrating innovation and shared decision-making in allergy and immunology practice	4
Atopic dermatitis: Best of guidelines and yardstick	4
Common but neglected problem in chronic spontaneous urticaria: Sleep disturbance	4
Allergy immunotherapy for allergic fungal respiratory diseases	4
Selective immunoglobulin E deficiency and its association with autoimmune and autoinflammatory diseases	4
Exploring mast cell disorders: Tryptases, hereditary alpha-tryptasemia, and MCAS treatment approaches	4
Prevalence and bidirectional association between rhinitis and urticaria: A systematic review and meta-analysis	4
Early-life risk factors for recurrent wheezing in preschool children: A meta-analysis of 15 cohort studies	3
Interaction between asthma and overweight/obesity on cancer results from the National Health and Nutrition Examination Survey 2005‐2018	3
For the patient	3
Becoming attack-free further improves health-related quality of life in patients with hereditary angioedema receiving garadacimab	3
Subcutaneous allergen immunotherapy in the treatment of allergic respiratory disease	3

Pediatric sublingual allergen immunotherapy	3
The challenge of neurologic disease for the allergist/immunologist	3
Hymenoptera venom immunotherapy: Safety and efficacy of an accelerated induction regimen with depot aluminum adsorbed extracts	3
Fruit allergy and anaphylaxis in children: Culprit fruits and clinical findings	3
Managing food allergies in each stage of life	3
Allergic comorbidities in fibromyalgia	3
Capturing total steroid burden in patients with atopic dermatitis and asthma	3
Addressing global health disparities in the management of RSV infection in infants and children: Strategies for preventing bronchiolitis and post-bronchiolitis recurrent wheezing	3
Diagnosis of ciprofloxacin hypersensitivity improves by incorporating MRGPRX2 in basophil activation test	3
United States Pharmacopeia guidance for compounding of allergenic extracts for allergen immunotherapy	3
Evaluation of different protocols for classification of pediatric hypersensitivity reactions to nonsteroidal anti-inflammatory drugs: Children with underlying allergic disease should be a separate sub	3
SNOT-22 scores after 6 months of aspirin therapy are predictive of long-term quality of life in AERD	3
Evaluation of sinonasal involvement in patients with asthma and chronic obstructive pulmonary disease	3
Impact of nasal congestion on intranasal rescue medication absorption and efficacy: A systematic review	3
Impact of baseline body mass index on asthma incidence in middle-aged and elderly populations: A prospective analysis from China	3
Accelerated/rush allergen immunotherapy	3
Health disparities investigated in a primary care penicillin allergy removal pathway	3
The third pandemic: The respiratory syncytial virus landscape and specific considerations for the allergist/immunologist	3
The complexities of allergic diseases continue to challenge the allergist-immunologist	3
Oral immunotherapy with sunflower seed butter and a review of seed allergy	3
Dose-response studies of methylated and nonmethylated CpG ODNs from Bifidobacterium longum subsp. infantis for optimizing Treg cell stimulation	3
Real-world quality of life in patients with hereditary angioedema receiving lanadelumab or other long-term prophylaxis	3
The medical management of chronic rhinosinusitis with nasal polyps and aspirin-exacerbated respiratory in the biologic age	3
Relationship between autoimmune diseases and serum basal immunoglobulin E levels in patients with common variable immunodeficiency	3
Caregiver perceptions of β-lactam allergy testing for serum sickness-like reactions	3